PrimeNeuro

Diagnosing autistic tendencies in kids at 6 months of age, 18 months earlier than the current standard, with follow-on support for parents and caregivers.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Philadelphia, PA, USA
  • Currency USD
  • Founded March 2018
  • Employees 2
  • Incorporation Type C-corp
  • Website primeneuro.com

Company Summary

PrimeNeuro is advancing a multi-modality technology platform for early prediction of the development of Autism Spectrum Disorder (ASD) in infants as young as 6 months old. We are starting with a clinically validated functional MRI technology that has been developed over the last 5 years. We are also developing Sprout, an app that supports parents and therapists.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free